The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
89160283 8916028 3 F 201101 20160920 20121119 20160927 EXP US-ASTRAZENECA-2011SE18748 ASTRAZENECA 775.00 MON F Y 87.10000 KG 20160927 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
89160283 8916028 1 PS SEROQUEL QUETIAPINE FUMARATE 1 Oral U U 20639 2 DF FILM-COATED TABLET QD
89160283 8916028 2 SS SEROQUEL QUETIAPINE FUMARATE 1 Oral U U 20639 2 DF FILM-COATED TABLET QD
89160283 8916028 3 SS SEROQUEL QUETIAPINE FUMARATE 1 Oral U U 20639 PROLONGED-RELEASE TABLET
89160283 8916028 4 SS SEROQUEL QUETIAPINE FUMARATE 1 Oral U U 20639 PROLONGED-RELEASE TABLET
89160283 8916028 5 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 40.0MG UNKNOWN U U 0 40 MG
89160283 8916028 6 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral 3060 MG U 0 20 MG TABLET QD
89160283 8916028 7 C RANITIDINE. RANITIDINE 1 MORINING 0
89160283 8916028 8 C GLUCOTROL XL GLIPIZIDE 1 10.0MG UNKNOWN 0 10 MG
89160283 8916028 9 C ACTOS PIOGLITAZONE HYDROCHLORIDE 1 0
89160283 8916028 10 C ENALAPRIL ENALAPRIL 1 40.0MG UNKNOWN 0 40 MG
89160283 8916028 11 C ENALAPRIL ENALAPRIL 1 20.0MG UNKNOWN 0 20 MG QD
89160283 8916028 12 C LIPITOR ATORVASTATIN CALCIUM 1 0
89160283 8916028 13 C ALLEGRA FEXOFENADINE HYDROCHLORIDE 1 0
89160283 8916028 14 C PAXIL PAROXETINE HYDROCHLORIDE 1 0
89160283 8916028 15 C XANAX ALPRAZOLAM 1 Oral 0 2.5 MG QD
89160283 8916028 16 C XANAX ALPRAZOLAM 1 0.5MG UNKNOWN 0 .5 MG
89160283 8916028 17 C FUMEX 2 1.0MG UNKNOWN 0 1 MG
89160283 8916028 18 C FUMEX 2 1.0MG UNKNOWN 0 1 MG
89160283 8916028 19 C STEROID UNSPECIFIED INGREDIENT 1 0
89160283 8916028 20 C MUCINEX GUAIFENESIN 1 0
89160283 8916028 21 C BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 0
89160283 8916028 22 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 0 2 DF QD
89160283 8916028 23 C GLIPIZIDE. GLIPIZIDE 1 Oral 0 5 MG BID
89160283 8916028 24 C ENAZEPRIL-HYDROCHLORIDE 2 Oral 0 20 MG QD
89160283 8916028 25 C ASPIRIN. ASPIRIN 1 Oral 0 325 MG QD
89160283 8916028 26 C CINNAMON. CINNAMON 1 Oral 0 500 MG QD
89160283 8916028 27 C FUROSEMIDE. FUROSEMIDE 1 Oral 20.0MG UNKNOWN 0 20 MG
89160283 8916028 28 C VITAMIN D CHOLECALCIFEROL 1 Oral 5000 UNITS 0
89160283 8916028 29 C OMEGA 3 FISH OIL FISH OILOMEGA-3 FATTY ACIDS 1 Oral 1200 UNITS 0
89160283 8916028 30 C CRANBERRY. CRANBERRY 1 Oral 0 QD
89160283 8916028 31 C CALCIUM-MAGNESIUM-POTASSIUM 2 Oral 500MG-500MG-99MG, DAILY 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
89160283 8916028 1 Sleep disorder
89160283 8916028 2 Insomnia
89160283 8916028 3 Sleep disorder
89160283 8916028 4 Insomnia
89160283 8916028 5 Dyspepsia
89160283 8916028 7 Dyspepsia
89160283 8916028 8 Diabetes mellitus
89160283 8916028 10 Blood pressure abnormal
89160283 8916028 11 Blood pressure abnormal
89160283 8916028 13 Sinus disorder
89160283 8916028 15 Insomnia
89160283 8916028 16 Insomnia
89160283 8916028 17 Fluid retention
89160283 8916028 18 Blood pressure measurement
89160283 8916028 22 Diabetes mellitus
89160283 8916028 23 Diabetes mellitus
89160283 8916028 24 Blood pressure abnormal
89160283 8916028 25 Anticoagulant therapy
89160283 8916028 26 Diabetes mellitus
89160283 8916028 27 Diuretic therapy
89160283 8916028 29 Cardiac disorder
89160283 8916028 30 Urinary tract infection

Outcome of event

Event ID CASEID OUTC COD
89160283 8916028 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
89160283 8916028 Cerebrovascular accident
89160283 8916028 Diabetes mellitus inadequate control
89160283 8916028 Drug dose omission
89160283 8916028 Drug ineffective for unapproved indication
89160283 8916028 Fatigue
89160283 8916028 Headache
89160283 8916028 Helicobacter infection
89160283 8916028 Herpes zoster
89160283 8916028 Intentional product misuse
89160283 8916028 Lower respiratory tract infection
89160283 8916028 Memory impairment
89160283 8916028 Neck pain
89160283 8916028 Pain
89160283 8916028 Product use issue
89160283 8916028 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
89160283 8916028 1 2010 2013 0
89160283 8916028 2 2010 2013 0
89160283 8916028 3 201409 0
89160283 8916028 4 201409 0
89160283 8916028 5 2010 0
89160283 8916028 6 201403 0
89160283 8916028 8 2002 0
89160283 8916028 11 201409 0
89160283 8916028 14 2002 0
89160283 8916028 15 1993 0
89160283 8916028 16 2012 0
89160283 8916028 22 201403 0
89160283 8916028 23 201509 0
89160283 8916028 24 201409 0
89160283 8916028 25 1992 0
89160283 8916028 26 201309 0
89160283 8916028 27 201409 0
89160283 8916028 28 2005 0
89160283 8916028 29 201409 0
89160283 8916028 30 201609 0
89160283 8916028 31 201603 0